Clinical trial
Merestinib on Bone Metastases in Subjects With Breast Cancer
NCT03292536
Study timeline
Study start (actual)2018-01-11Date precision: day
Registry last updated2021-01-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Bone Metastasesunresolved
Breast Cancerunresolved
Interventions
MerestinibDRUG
Sponsors & collaborators
University of Utahlead sponsor
Eli Lilly and Companycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03292536 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.